Kyntra Bio (KYNB) 2025 Earnings Outlook: Key Trends
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
First-time investors should be aware of common mistakes that can lead to losses. Here’s what not to do for a successful start.
28,109 articlesKyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
Value stocks are regaining ground in May as investors rotate from growth; the VLUE, AVUV, and VBR trio are delivering...
Bank of America's Vivek Arya sees Nvidia climbing to $350 as AI-driven demand sustains a broad, structural shift in c...
A robust May jobs report upends expectations for a large 2027 COLA, threatening the size of social security’s billion...
As Congress stalls on federal AI regulation, states are advancing targeted laws on chatbot interactions, employer use...
Shiba Inu (SHIB) slid to a five-year bottom amid broad market pullback, then staged an abrupt comeback that tightened...
Tesla faces a pivotal three-year outlook as margins recover and AI initiatives expand. Analysts sketch a base case ar...
Micron’s latest earnings hints at a longer memory cycle, potentially lifting these memory ETFs through 2027. Here’s h...
Shake Shack delivered a blowout Q4, where earnings beat expectations by a wide margin and revenue surged. The company...
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
Ireland is courting U.S. firms with a wave of investment deals announced during a Washington visit, signaling a conti...
As 2026 unfolds, smart glasses are poised for a pivotal year, led by Meta and Google. Apple sits on the sidelines wit...